Video: Letting Nature Lead – with John Maher - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Video: Letting Nature Lead – with John Maher

  • November 16, 2026

  • 1 min

Share

Clinical Scorecard: Video: Letting Nature Lead – with John Maher

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Video
Key MechanismsMechanisms or clinical associations described in the source article.
Target PopulationNot described in the source.
Care SettingMaher’s career combines academic research, clinical practice, and cell-therapy development through Leucid Bio.

Key Highlights

  • John Maher is a clinical immunologist, Scientific Founder and Chief Scientific Officer of Leucid Bio.
  • He leads the CAR Mechanics research group at King’s College London.
  • His work in CAR T-cell immunotherapy spans more than two decades, with a particular focus on developing treatments for solid tumors.
  • While working in Michel Sadelain’s laboratory at Memorial Sloan Kettering Cancer Center, Maher helped develop second-generation CAR technology incorporating CD28; the approach subsequently achieved clinical success in blood cancers.
  • The interview covers his route into immunology, contributions to CAR T development, and the scientific thinking behind his current research.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          The source describes Maher’s work in CAR T-cell immunotherapy, particularly development of treatments for solid tumors; it does not specify a patient population.

          The source describes his contribution to second-generation CAR technology incorporating CD28 and his current research, but gives no treatment protocol details.

          Clinical Best Practices

            Related Resources & Content

              Original Source(s)

              Related Content